Back to top Open menu arrow
Download Reprints
Sections
METHODS RESULTS DISCUSSION Clinical Points
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

Original Research January 25, 2023

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

J Clin Psychiatry 2023;84(2):22m14379

This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

ABSTRACT

Objective: Attention-deficit/hyperactivity disorder (ADHD) is associated with a range of adverse outcomes in adult life. However, it is unclear whether the risk pathways to adverse adult outcomes are established during childhood or whether associations are driven by concurrent ADHD symptoms that have persisted to adulthood.

Methods: We examined associations between broadly defined child-limited (remitted) and persistent ADHD (assessed using the ADHD subscale of the Strengths and Difficulties Questionnaire) with negative social outcomes (low emotional and instrumental support, antisocial behavior, employment, receipt of state benefits as an indicator of socio-economic disadvantage, homelessness) at age 25 years in a UK longitudinal population sample, the Avon Longitudinal Study of Parents and Children (age 25 data collected between years 2017 and 2018; total N = 6,439).

Results: Up to 20% of young people with less favorable social outcomes at age 25 had persistent ADHD. Persistent ADHD was associated with an increased likelihood of being not in education, employment, or training (NEET) (OR = 3.71, 95% CI = 2.06 to 6.67, P = 1 × 10−05) and receiving state benefits (OR = 2.72, 95% CI = 1.62 to 4.57, P = 2 × 10−04) at age 25 years compared to those without ADHD. We did not find strong evidence of associations between child-limited ADHD and social outcomes (NEET OR = 1.20, 95% CI = 0.54 to 2.69, P = .65; state benefits OR = 1.38, 95% CI = 0.76 to 2.51, P = .29). Persistent ADHD associations with negative social outcomes were observed across family-of-origin income groups and sex and were not explained by comorbidity.

Conclusions: Our findings highlight the importance of continued monitoring and management of ADHD symptoms and related social as well as clinical outcomes across development into adulthood. Future research is needed to identify what factors promote positive social outcomes, including effective treatment of adult ADHD symptoms.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–165. PubMed CrossRef
  2. Riglin L, Collishaw S, Thapar AK, et al. Association of genetic risk variants with attention-deficit/hyperactivity disorder trajectories in the general population. JAMA Psychiatry. 2016;73(12):1285–1292. PubMed CrossRef
  3. Garas P, Balazs J. Long-term suicide risk of children and adolescents with attention deficit and hyperactivity disorder—a systematic review. Front Psychiatry. 2020;11:557909. PubMed CrossRef
  4. Groenman AP, Janssen TWP, Oosterlaan J. Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(7):556–569. PubMed CrossRef
  5. Klein RG, Mannuzza S, Olazagasti MA, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry. 2012;69(12):1295–1303. PubMed CrossRef
  6. Septier M, Stordeur C, Zhang J, et al. Association between suicidal spectrum behaviors and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;103:109–118. PubMed CrossRef
  7. Langley K, Fowler T, Ford T, et al. Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry. 2010;196(3):235–240. PubMed CrossRef
  8. Young S, Moss D, Sedgwick O, et al. A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psychol Med. 2015;45(2):247–258. PubMed CrossRef
  9. Erskine HE, Norman RE, Ferrari AJ, et al. Long-term outcomes of attention-deficit/hyperactivity disorder and conduct disorder: a systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2016;55(10):841–850. PubMed CrossRef
  10. Gordon CT, Fabiano GA. The transition of youth with ADHD into the workforce: review and future directions. Clin Child Fam Psychol Rev. 2019;22(3):316–347. PubMed CrossRef
  11. Merrill BM, Molina BS, Coxe S, et al. Functional outcomes of young adults with childhood ADHD: A latent profile analysis. J Clin Child Adolesc Psychol. 2019;49(2):215–228. PubMed
  12. Bruner MR, Kuryluk AD, Whitton SW. Attention-deficit/hyperactivity disorder symptom levels and romantic relationship quality in college students. J Am Coll Health. 2015;63(2):98–108. PubMed CrossRef
  13. Wymbs BT, Canu WH, Sacchetti GM, et al. Adult ADHD and romantic relationships: What we know and what we can do to help. J Marital Fam Ther. 2021;47(3):664–681. PubMed CrossRef
  14. Chang Z, D’Onofrio BM, Quinn PD, et al. Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study. Biol Psychiatry. 2016;80(12):916–922. PubMed CrossRef
  15. Riglin L, Leppert B, Dardani C, et al. ADHD and depression: investigating a causal explanation. Psychol Med. 2020;51(11):1890–1897. PubMed
  16. Leppert B, Riglin L, Dardani C, et al. ADHD genetic liability and physical health outcomes: a two-sample Mendelian randomization study. bioRxiv. 2019:630467.</prpt>
  17. Agnew-Blais JC, Polanczyk GV, Danese A, et al. Young adult mental health and functional outcomes among individuals with remitted, persistent and late-onset ADHD. Br J Psychiatry. 2018;213(3):526–534. PubMed CrossRef
  18. Boyd A, Golding J, Macleod J, et al. Cohort profile: the “children of the 90s”: the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2013;42(1):111–127. PubMed CrossRef
  19. Fraser A, Macdonald-Wallis C, Tilling K, et al. Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol. 2013;42(1):97–110. PubMed CrossRef
  20. Northstone K, Lewcock M, Groom A, et al. The Avon Longitudinal Study of Parents and Children (ALSPAC): an update on the enrolled sample of index children in 2019. Wellcome Open Res. 2019;4:51. PubMed CrossRef
  21. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. PubMed CrossRef
  22. Goodman R. The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997;38(5):581–586. PubMed CrossRef
  23. Riglin L, Agha SS, Eyre O, et al. Investigating the validity of the Strengths and Difficulties Questionnaire to assess ADHD in young adulthood. Psychiatry Res. 2021;301:113984. PubMed CrossRef
  24. Riglin L, Wootton RE, Livingston LA, et al. “Late-onset” ADHD symptoms in young adulthood: is this ADHD? J Atten Disord. 2022;26(10):1271–1282. PubMed CrossRef
  25. Cyranowski JM, Zill N, Bode R, et al. Assessing social support, companionship, and distress: National Institute of Health (NIH) Toolbox Adult Social Relationship Scales. Health Psychol. 2013;32(3):293–301. PubMed CrossRef
  26. Smith DJ, McVie S. Theory and method in the edinburgh study of youth transitions and crime. Br J Criminol. 2003;43(1):169–195. CrossRef
  27. Watson B. Young people not in education, employment or training (NEET), UK: February 2020: estimates of young people (aged 16 to 24 years) who are not in education, employment or training, by age and sex. Office for National Statistics. 2020. https://www.ons.gov.uk/employmentandlabourmarket/peoplenotinwork/unemployment/bulletins/youngpeoplenotineducationemploymentortrainingneet/february2020
  28. Wechsler D, Golombok S, Rust J. WISC-III UK Wechsler Intelligence Scale for Children: UK Manual. The Psychological Corporation; 1992.
  29. Skuse DH, Mandy WP, Scourfield J. Measuring autistic traits: heritability, reliability and validity of the Social and Communication Disorders Checklist. Br J Psychiatry. 2005;187(6):568–572. PubMed CrossRef
  30. Seaman SR, White IR, Copas AJ, et al. Combining multiple imputation and inverse-probability weighting. Biometrics. 2012;68(1):129–137. PubMed CrossRef
  31. Wilens TE, Adamson J, Monuteaux MC, et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008;162(10):916–921. PubMed CrossRef
  32. Biederman J, Monuteaux MC, Spencer T, et al. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008;165(5):597–603. PubMed CrossRef
  33. Caye A, Spadini AV, Karam RG, et al. Predictors of persistence of ADHD into adulthood: a systematic review of the literature and meta-analysis. Eur Child Adolesc Psychiatry. 2016;25(11):1151–1159. PubMed CrossRef
  34. Martin J, Tilling K, Hubbard L, et al. Association of genetic risk for schizophrenia with nonparticipation over time in a population-based cohort study. Am J Epidemiol. 2016;183(12):1149–1158. PubMed CrossRef
  35. Taylor AE, Jones HJ, Sallis H, et al. Exploring the association of genetic factors with participation in the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2018;47(4):1207–1216. PubMed CrossRef
  36. Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387(10024):1240–1250. PubMed CrossRef
Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

Save Save

Share Share

Cite Cite